Dr. Neil D. Belman
Claim this profileSaint Luke's University Hospital-Bethlehem Campus
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
4 reported clinical trials
8 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
Stage II
Stage I
2Lung Cancer
Stage IV
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Neil D. Belman is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Neil D. Belman
Clinical Trial Related9 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Neil D. Belman has experience with
- Biospecimen Collection
- Crizotinib
- Cabozantinib S-malate
- Nivolumab
- Nab-paclitaxel
- Paxalisib
Breakdown of trials Neil D. Belman has run
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
ALK Gene Rearrangement
Lung Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Neil D. Belman specialize in?
Neil D. Belman focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage II.
Is Neil D. Belman currently recruiting for clinical trials?
Yes, Neil D. Belman is currently recruiting for 3 clinical trials in Bethlehem Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Neil D. Belman has studied deeply?
Yes, Neil D. Belman has studied treatments such as Biospecimen Collection, Crizotinib, Cabozantinib S-malate.
What is the best way to schedule an appointment with Neil D. Belman?
Apply for one of the trials that Neil D. Belman is conducting.
What is the office address of Neil D. Belman?
The office of Neil D. Belman is located at: Saint Luke's University Hospital-Bethlehem Campus, Bethlehem, Pennsylvania 18015 United States. This is the address for their practice at the Saint Luke's University Hospital-Bethlehem Campus.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.